Ramot at Tel Aviv University Ltd. and Neurimmune Announce Sponsored Research Agreement for Alzheimer’s Disease Treatment

28.07.2015

Novel anti-ApoE antibodies to be developed for Alzheimer's disease treatment under a research and options agreement that includes pre-negotiated licensing terms for all ApoE-based products.

News overview

This website uses cookies, with the aim of ensuring that you have the best possible online experience. In using our website, you are giving your consent to the terms and conditions of our Privacy policy

Your web browser is out of date

Update your browser for more security, speed and the best experience.

Update my browser Continue